Article
Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Mar 2009
Chang Ellen T, Birmann Brenda M, Kasperzyk Julie L, Conti David V, Kraft Peter, Ambinder Richard F, Zheng Tongzhang, Mueller Nancy E
Abstract excerpt
We found that regular use of aspirin may reduce the risk of Hodgkin lymphoma (HL), a common cancer of adolescents and young adults in the United States. To explore possible biological mechanisms underlying this association, we investigated whether polymorphic variation in genes involved in nuclear factor-kappaB (NF-kappaB) activation and inhibition, other inflammatory pathways, and aspirin metabolism influences...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
